Dr. Evelegh received his PhD, Immunology from McMaster University and his BSc, Biology, from Laurentian University. His research
interests include regulatory and clinical management of medical devices to obtain clearance from regulatory bodies as well as the
development of novel technologies applicable to in vitro diagnostics.
Dr. Evelegh is one of the co-developers of the PreVu Non-Invasive
Skin Cholesterol Test technology and a former Vice President, Clinical and Regulatory Affairs at PreMD Inc., the company that formerly
owned PreVu. Dr. Evelegh and his colleagues at The Cleveland Clinic Foundation studied the ground-breaking relationship between Skin
Cholesterol and a positive stress test (Clinical Chemistry 47, No. 7, 2001). The data revealed a strong correlation between elevated
levels of Skin Cholesterol and abnormal treadmill stress-test results related to establishing risk for coronary artery disease. As
Vice President, Product Development Dr. Evelegh is involved in overseeing all aspects of PreVu technology advancement and testing,
including the development of new product platforms.
Dr. Evelegh also continues to serve as an Assistant Professor at the Department
of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University (part-time). He has over 20 years of experience
in researching and developing human diagnostics, including product development, clinical trials, regulatory submissions and
John Maynard possesses a Master of Science degree in Electrical Engineering and a Bachelor of Science degree in Electrical Engineering, both from Stanford University (1987 and 1986, respectively). He is registered as co-inventor on 19 U.S. patents, and has been the co-author of 18 peer-reviewed publications. John was co-founder of Veralight Inc. which developed the Scout DS® screening device for prediabetes and type-2 diabetes, and which Miraculins acquired all the relevant assets of (related to the Scout DS®) in 2013.
In his multiple roles with VeraLight over the years as VP of Development and Engineering, VP of Technology, and Executive VP, Mr. Maynard played a senior leadership role that saw the Scout DS® progressively advance through its early stages of feasibility studies and clinical prototypes, through to its final development as a commercially viable and clinically validated device. He was instrumental in leading the teams that created and tested clinical prototypes of the Scout DS®, outlined and executed clinical trial development plans, achieved and implemented an ISO 9001 and 13485 quality manufacturing certification, collaborated with key opinion leaders and diabetes researchers, secured regulatory clearance for Scout DS® from Health Canada and a CE-Mark for the device in the EU, and introduced the Scout DS® into select international markets.
Mr. Maynard provides medical device, diagnostics and employee wellness consulting services to clients with a focus on product development, clinical trials, regulatory strategy, medical and scientific community outreach, market development, complex sales, competitive assessment and intellectual property.
James Overbeck has a dynamic record of leadership and entrepreneurial performance with 25 years of experience in technology driven markets. Mr. Overbeck is the founder of Q Product Management LLC, a product development company interfacing with clients building or rejuvenating their businesses.
Leveraging skills from his career and using techniques honed in the University of Michigan's Executive Multidisciplinary Action Project, he assists and executes projects across a variety of markets. Customers include multi-national companies launching new ventures, medical device start-ups, and venture capitalists considering new technical opportunities. He delivers world class solutions for clients by mapping customer requests to actionable plans for internal and external resources. His unique lean methodology keeps creatives and intellectuals focused on customers during new product development.
During his 21 year tenure at X-Rite Incorporated, Mr. Overbeck was instrumental in strategic interaction with large OEM's yielding multi-year supply contracts. Interfacing with patent attorneys and outside talent he successfully injected new business ideas and technologies into X-Rite's portfolio assuring long term market leadership and profitability. One resulting product was awarded Reality's Most Innovative Product of the year and achieved first year sales of $1.3M. As leader of X-Rite's software development staff, he grew that team from a single DOS developer to an industry-leading group of 20 Windows developers, translators and test resources that worked together to create a family of products generating over $10M in annual sales. Mr. Overbeck graduated from the University of Michigan's Steven M. Ross Business School where he received an MBA with distinction. He also holds a Bachelor of Science degree in Electrical Engineering from Calvin College, Grand Rapids, MI.
Type your email address here:
I want email updates for:
Career Opportunitiesinvestor relationsmiraculins news